Guest guest Posted August 27, 1999 Report Share Posted August 27, 1999 I found this on TOBI at the FDA site...what is " MIC " ? Thanks! Kay W. FOOD AND DRUG ADMINISTRATION + + + + + ANTI-INFECTIVE DRUGS ADVISORY COMMITTEE + + + + + 62ND MEETING + + + + + FRIDAY, NOVEMBER 21, 1997 First, does treatment with TOBI change the tobramycin susceptibility of P. aeruginosa? Yes. As might be expected with antibiotic therapy, a small percentage of patients with TOBI had organisms with increased MICs. However, 85 percent of patients receiving TOBI had organisms of unchanged or decreased MICs over the six-month study. Second, is there an MIC value above which no clinical response to TOBI occurs? No. With the current data, we did not find an MIC value above which no clinical response to TOBI occurs. It is clear that the tobramycin parenteral break point of 16 micrograms per ml does not apply to TOBI therapy. And, last, does treatment with TOBI change the sputum microbial flora? No. Treatment with TOBI does not appear to cause clinically important changes to sputum microbial flora. The risk of superinfection with Burkholderia cepacia, Stenotrophomonas maltophilia, Alcaligenes xylosoxidans was not increased. Fungal isolation was increased. However, there was no apparent clinical significance to this finding Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.